EU MDR post-market surveillance · PMCF data collection · regulatory documents
Post-market clinical evidence and regulatory documents for medical device manufacturers.
We collect your PMCF data on our platform and deliver the PMCF report, PSUR and CER update with qualified partner medical writers, in one engagement.
- ePRO · RPM · eConsent · EDC · CTMS available
- AI Analytics in development

Demonstration study · illustrative figures
- APDC Health Award 2025
- WSA Portugal 2024
- Global Leverage Award 2026 · finalist
- Frontiers Health 2026 · Start-up Discovery, Berlin
- Partners: Analog Devices · Thryve · IPN · TB4Health · ULS Santa Maria · ULS Coimbra · PCI (Creative Science Park) · Innosuisse · Venturelab
What we do
Three offers for the organisations that produce clinical evidence.
From the clinical investigation to post-market follow-up: documents and data for the whole device lifecycle.
How it works
Four steps for post-market evidence and regulatory documents.
Scoping call
Thirty minutes on your device family, your markets and the inputs you already hold.
Written proposal within one week
Scope, documents, data collection plan and indicative timeframes, in writing, within one week of the scoping call.
Data collection on the platform
PMCF surveys, patient-reported outcomes and clinician follow-up are collected in one dataset with a full audit trail.
Documents delivered within the indicative timeframes
Qualified partner medical writers prepare the documents under our quality oversight.
Indicative timeframes from receipt of complete inputs; confirmed in the written proposal after scoping.
Platform modules
Five modules are available today and AI Analytics is in development. Use them individually or together, with the CONNECT integration layer for the systems you already run. The status of each module is stated on its card.
The product
One record for the investigator and the participant.
Investigators follow vital signs, events and documents per participant. Participants see their own readings and report events from their phone.



Platform screens with placeholder data
See the platform in action
Vitruvian Shield platform overview
Trust and compliance
Designed for regulated clinical research. The status of each framework is stated plainly; nothing here is a certification claim.
ALCOA++
Designed to supportDesigned to support ALCOA++ data-integrity principles. ALCOA++ is a set of principles, not a certification.
EU GDPR
Designed to supportDesigned to support GDPR requirements, with a Data Protection Impact Assessment per study, an Article 28 data processing agreement and EU hosting by default.
HIPAA
Designed to supportPlatform architecture designed to support the HIPAA Administrative, Physical and Technical Safeguards.
ISO 27001
Implementation in progressISO 27001: implementation in progress. No certificate has been issued to date.
ICH E6(R3) GCP
Designed to supportDesigned to support sponsors and CROs in meeting ICH E6(R3) expectations. The principles and Annex 1 have applied in the EU since 23 July 2025; Annex 2 applies from 15 January 2027.
FDA 21 CFR Part 11
Designed to supportElectronic records and audit trails designed to support 21 CFR Part 11; formal validation is planned.
Technology, clinical and ecosystem partners
Recognition
- European CEO of the Year 2024-2025Awarded to Paulo Martins
- Portuguese National Innovation Award 2024Awarded to Paulo Martins
- APDC Health Award, First Place 2025
- World Summit Awards Portugal 2024 Winner
- Finalist, Global Leverage Award 2026
- Frontiers Health 2026, Berlin
- Independent expert review completed through IPN healthproof, May 2026
Questions and answers
Frequently asked questions about Vitruvian Shield
What is Vitruvian Shield?
Vitruvian Shield provides post-market clinical evidence and regulatory documents for medical device manufacturers, and hybrid trial platform components for CROs and sponsors. Clinical data is collected on the Vitruvian Shield platform. Regulatory documents are written by qualified partner medical writers under our quality oversight. The company is headquartered in Switzerland with entities in Portugal, Armenia and the UAE.
Does Vitruvian Shield replace our EDC?
Only if you want it to. The platform components can be used individually or together. A sponsor can keep an EDC such as Medidata, Veeva or Oracle and add eConsent, ePRO and remote patient monitoring beside it through the CONNECT integration layer, or run the study on the platform's own EDC and CTMS.
Who uses Vitruvian Shield?
Medical device manufacturers that need post-market clinical follow-up data and regulatory documents; CROs and sponsors running hybrid studies; and academic investigators and clinical trial units running investigator-initiated research.
Which platform modules are available today?
Five modules are available: ePRO, remote patient monitoring, eConsent, electronic data capture and CTMS. AI analytics is in development. Each module page states its own status.
Is Vitruvian Shield ISO 27001 certified?
No. ISO 27001: implementation in progress. No certificate has been issued to date. The platform is designed to support GDPR, HIPAA, ALCOA++, ICH E6(R3) and FDA 21 CFR Part 11. Hosting is on Microsoft Azure in European Union regions.
How do we start working with Vitruvian Shield?
Book a 30-minute scoping call. A written proposal follows within one week of the call.
Who writes the regulatory documents?
The documents are written by qualified partner medical writers with EU medical device experience, under Vitruvian Shield's contract and quality oversight.
How long does a PSUR or PMCF report take?
A periodic safety update report is delivered within 4 weeks of receiving complete input data. A PMCF evaluation report is delivered within 4 weeks of receiving complete PMCF data. A clinical evaluation plan and clinical evaluation report update are delivered within 4 to 6 weeks of receiving complete input data. Indicative timeframes from receipt of complete inputs; confirmed in the written proposal after scoping.
Do you prepare clinical investigation documents?
Yes. The clinical investigation application dossier (technical and clinical parts), the investigator's brochure and the clinical investigation plan are prepared by qualified partner medical writers under our quality oversight; protocols are developed together with the sponsor and the investigators. Timeframe defined in the written proposal after scoping.
Can we use the platform without the document service?
Yes. The platform components (CTMS, EDC, eConsent, ePRO, remote patient monitoring and the CONNECT integration layer) can be used individually or together, with or without the regulatory document service.
ICH E6(R3) Annex 2 · EU, 15 January 2027
- Remote consent
- Data from digital health technologies
- Investigator oversight of activities outside the site
The platform is designed to support sponsors and CROs in meeting these expectations.
Book a demonstrationScoping call · video call
Book a scoping call.
Tell us about your device family or your study. A written proposal follows within one week of the call. Calls in English, French, German, Portuguese and Spanish.
Monday to Friday, 08:00 to 18:00 Zurich time





